HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: LVMH/Douglas

This article was originally published in The Rose Sheet

Executive Summary

LVMH/Douglas: Sign cross-shareholding deal under which Moet Hennessy Louis Vuitton will acquire a 30% stake in U.K. retailer Douglas International, and Douglas will take on a 30% interest in LVMH's Paris-based fragrance and beauty retailer Sephora, LVMH announced Sept. 22. The deal will "enhance the value of Sephora and Douglas...through international development of their respective distribution networks," LVMH said. Douglas operates 190 Parfumerie Douglas stores in Europe and the U.S. and generated sales of $253 mil, in 1996. Sephora, which LVMH acquired for $258.7 mil. on July 23, operates 54 retail stores worldwide ("The Rose Sheet" Aug. 4, In Brief). Separately, LVMH reported net sales up 61.5% to $3.67 bil. Net income excluding unusual items climbed 10% to $289 mil. On a comparable basis, excluding goodwill amortization, net income would have increased 8.5%...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel